AKT1 and plasma cell myeloma: To investigate the possible involvement of PI3K‐AKT signal pathway in the CCN1 stimulating effect on osteoblasts, we first test our osteoblasts samples from both myeloma patients and healthy donors by PI3K‐AKT specific intracellular signaling antibody array.